SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 7.21 |
Enterprise Value ($M) | 1.60 |
Book Value ($M) | 24.22 |
Book Value / Share | 13.80 |
Price / Book | 0.30 |
NCAV ($M) | 6.91 |
NCAV / Share | 3.94 |
Price / NCAV | 1.04 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.68 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -0.49 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.63 |
Current Ratio | 2.40 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 13.94 |
Assets | 31.24 |
Liabilities | 7.03 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 17.42 |
Operating Income | -15.59 |
Net Income | -17.90 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -11.51 |
Cash from Investing | 4.69 |
Cash from Financing | 0.66 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Farallon Capital Management Llc | 0.00 | -100.00 | |
13D/A | Detwiler Kyle | 4.90 | 2.56 | |
13D/A | Schultze Special Purpose Acquisition Sponsor, LLC | 0.00 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
9,906 | 25,493 | 38.86 | |
24 | 237 | 10.13 | |
2,775 | 710 | 390.85 | |
505 | 1,551 | 32.56 | |
229 | 3,630 | 6.31 | |
(click for more detail) |
Similar Companies | |
---|---|
CLDX – Celldex Therapeutics, Inc. | CLNN – Clene Inc. |
CLRB – Cellectar Biosciences, Inc. | CMPX – Compass Therapeutics, Inc. |
CNSP – CNS Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io